Report cover image

Global Biologic Therapeutic Drug Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 191 Pages
SKU # APRC20356254

Description

Summary

According to APO Research, The global Biologic Therapeutic Drug market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Biologic Therapeutic Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Biologic Therapeutic Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Biologic Therapeutic Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Biologic Therapeutic Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Biologic Therapeutic Drug include Merck and Co. Inc., Pfizer Inc., AstraZeneca, Smith Medical, Retractable Technologies, Inc., Novartis Global, H. Lundbeck A/S, GlaxoSmithKline Plc. and Concord Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Biologic Therapeutic Drug, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Biologic Therapeutic Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Biologic Therapeutic Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biologic Therapeutic Drug revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Biologic Therapeutic Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Biologic Therapeutic Drug revenue, projected growth trends, production technology, application and end-user industry.

Biologic Therapeutic Drug Segment by Company

Merck and Co. Inc.
Pfizer Inc.
AstraZeneca
Smith Medical
Retractable Technologies, Inc.
Novartis Global
H. Lundbeck A/S
GlaxoSmithKline Plc.
Concord Biotech
Aurobindo Pharma Ltd.
Biologic Therapeutic Drug Segment by Type

Monoclonal Antibodies
Vaccines
Therapeutic Proteins
Biologic Therapeutic Drug Segment by Application

Clinical Medicine
Laboratory
Others
Biologic Therapeutic Drug Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologic Therapeutic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biologic Therapeutic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologic Therapeutic Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Biologic Therapeutic Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biologic Therapeutic Drug industry.
Chapter 3: Detailed analysis of Biologic Therapeutic Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologic Therapeutic Drugrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.

Table of Contents

191 Pages
1 Market Overview
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Biologic Therapeutic Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Vaccines
1.2.4 Therapeutic Proteins
1.3 Market Analysis by Application
1.3.1 Global Biologic Therapeutic Drug Market Size Growth Rate by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Medicine
1.3.3 Laboratory
1.3.4 Others
1.4 Global Market Growth Prospects
1.5 Global Biologic Therapeutic Drug Growth Trends by Region
1.5.1 Global Biologic Therapeutic Drug Market Size by Region: 2020 VS 2024 VS 2031
1.5.2 Biologic Therapeutic Drug Market Size by Region (2020-2025)
1.5.3 Biologic Therapeutic Drug Market Size by Region (2026-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 Global Biologic Therapeutic Drug Market Dynamics
2.1 Biologic Therapeutic Drug Industry Trends
2.2 Biologic Therapeutic Drug Industry Drivers
2.3 Biologic Therapeutic Drug Industry Opportunities and Challenges
2.4 Biologic Therapeutic Drug Industry Restraints
3 Competitive Landscape by Company
3.1 Global Biologic Therapeutic Drug Revenue by Company (2020-2025)
3.2 Global Biologic Therapeutic Drug Players Revenue Ranking, 2023 VS 2024 VS 2025
3.3 Global Biologic Therapeutic Drug Key Company Head office and Area Served
3.4 Global Biologic Therapeutic Drug Company, Product Type & Application
3.5 Global Biologic Therapeutic Drug Company Establishment Date
3.6 Market Competitive Analysis
3.6.1 Global Biologic Therapeutic Drug Market CR5 and HHI
3.6.2 Global Top 5 and 10 Biologic Therapeutic Drug Players Market Share by Revenue in 2024
3.6.3 2024 Biologic Therapeutic Drug Tier 1, Tier 2, and Tier 3
4 Biologic Therapeutic Drug Market by Type
4.1 Global Biologic Therapeutic Drug Market Size by Type (2020 VS 2024 VS 2031)
4.2 Global Biologic Therapeutic Drug Market Size by Type (2020-2031)
4.3 Global Biologic Therapeutic Drug Market Size Share by Type (2020-2031)
5 Biologic Therapeutic Drug Market by Application
5.1 Global Biologic Therapeutic Drug Market Size by Application (2020 VS 2024 VS 2031)
5.2 Global Biologic Therapeutic Drug Market Size by Application (2020-2031)
5.3 Global Biologic Therapeutic Drug Market Size Share by Application (2020-2031)
6 Company Profiles
6.1 Merck and Co. Inc.
6.1.1 Merck and Co. Inc. Comapny Information
6.1.2 Merck and Co. Inc. Business Overview
6.1.3 Merck and Co. Inc. Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2020-2025)
6.1.4 Merck and Co. Inc. Biologic Therapeutic Drug Product Portfolio
6.1.5 Merck and Co. Inc. Recent Developments
6.2 Pfizer Inc.
6.2.1 Pfizer Inc. Comapny Information
6.2.2 Pfizer Inc. Business Overview
6.2.3 Pfizer Inc. Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2020-2025)
6.2.4 Pfizer Inc. Biologic Therapeutic Drug Product Portfolio
6.2.5 Pfizer Inc. Recent Developments
6.3 AstraZeneca
6.3.1 AstraZeneca Comapny Information
6.3.2 AstraZeneca Business Overview
6.3.3 AstraZeneca Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2020-2025)
6.3.4 AstraZeneca Biologic Therapeutic Drug Product Portfolio
6.3.5 AstraZeneca Recent Developments
6.4 Smith Medical
6.4.1 Smith Medical Comapny Information
6.4.2 Smith Medical Business Overview
6.4.3 Smith Medical Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2020-2025)
6.4.4 Smith Medical Biologic Therapeutic Drug Product Portfolio
6.4.5 Smith Medical Recent Developments
6.5 Retractable Technologies, Inc.
6.5.1 Retractable Technologies, Inc. Comapny Information
6.5.2 Retractable Technologies, Inc. Business Overview
6.5.3 Retractable Technologies, Inc. Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2020-2025)
6.5.4 Retractable Technologies, Inc. Biologic Therapeutic Drug Product Portfolio
6.5.5 Retractable Technologies, Inc. Recent Developments
6.6 Novartis Global
6.6.1 Novartis Global Comapny Information
6.6.2 Novartis Global Business Overview
6.6.3 Novartis Global Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2020-2025)
6.6.4 Novartis Global Biologic Therapeutic Drug Product Portfolio
6.6.5 Novartis Global Recent Developments
6.7 H. Lundbeck A/S
6.7.1 H. Lundbeck A/S Comapny Information
6.7.2 H. Lundbeck A/S Business Overview
6.7.3 H. Lundbeck A/S Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2020-2025)
6.7.4 H. Lundbeck A/S Biologic Therapeutic Drug Product Portfolio
6.7.5 H. Lundbeck A/S Recent Developments
6.8 GlaxoSmithKline Plc.
6.8.1 GlaxoSmithKline Plc. Comapny Information
6.8.2 GlaxoSmithKline Plc. Business Overview
6.8.3 GlaxoSmithKline Plc. Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2020-2025)
6.8.4 GlaxoSmithKline Plc. Biologic Therapeutic Drug Product Portfolio
6.8.5 GlaxoSmithKline Plc. Recent Developments
6.9 Concord Biotech
6.9.1 Concord Biotech Comapny Information
6.9.2 Concord Biotech Business Overview
6.9.3 Concord Biotech Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2020-2025)
6.9.4 Concord Biotech Biologic Therapeutic Drug Product Portfolio
6.9.5 Concord Biotech Recent Developments
6.10 Aurobindo Pharma Ltd.
6.10.1 Aurobindo Pharma Ltd. Comapny Information
6.10.2 Aurobindo Pharma Ltd. Business Overview
6.10.3 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2020-2025)
6.10.4 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Product Portfolio
6.10.5 Aurobindo Pharma Ltd. Recent Developments
7 North America
7.1 North America Biologic Therapeutic Drug Market Size (2020-2031)
7.2 North America Biologic Therapeutic Drug Market Size by Type
7.2.1 North America Biologic Therapeutic Drug Market Size by Type (2020-2025)
7.2.2 North America Biologic Therapeutic Drug Market Size by Type (2026-2031)
7.2.3 North America Biologic Therapeutic Drug Market Share by Type (2020-2031)
7.3 North America Biologic Therapeutic Drug Market Size by Application
7.3.1 North America Biologic Therapeutic Drug Market Size by Application (2020-2025)
7.3.2 North America Biologic Therapeutic Drug Market Size by Application (2026-2031)
7.3.3 North America Biologic Therapeutic Drug Market Share by Application (2020-2031)
7.4 North America Biologic Therapeutic Drug Market Size by Country
7.4.1 North America Biologic Therapeutic Drug Market Size by Country (2020 VS 2024 VS 2031)
7.4.2 North America Biologic Therapeutic Drug Market Size by Country (2020-2025)
7.4.3 North America Biologic Therapeutic Drug Market Size by Country (2026-2031)
7.4.4 North America Biologic Therapeutic Drug Market Share by Country (2020-2031)
7.4.5 United States
7.4.6 Canada
7.4.7 Mexico
8 Europe
8.1 Europe Biologic Therapeutic Drug Market Size (2020-2031)
8.2 Europe Biologic Therapeutic Drug Market Size by Type
8.2.1 Europe Biologic Therapeutic Drug Market Size by Type (2020-2025)
8.2.2 Europe Biologic Therapeutic Drug Market Size by Type (2026-2031)
8.2.3 Europe Biologic Therapeutic Drug Market Share by Type (2020-2031)
8.3 Europe Biologic Therapeutic Drug Market Size by Application
8.3.1 Europe Biologic Therapeutic Drug Market Size by Application (2020-2025)
8.3.2 Europe Biologic Therapeutic Drug Market Size by Application (2026-2031)
8.3.3 Europe Biologic Therapeutic Drug Market Share by Application (2020-2031)
8.4 Europe Biologic Therapeutic Drug Market Size by Country
8.4.1 Europe Biologic Therapeutic Drug Market Size by Country (2020 VS 2024 VS 2031)
8.4.2 Europe Biologic Therapeutic Drug Market Size by Country (2020-2025)
8.4.3 Europe Biologic Therapeutic Drug Market Size by Country (2026-2031)
8.4.4 Europe Biologic Therapeutic Drug Market Share by Country (2020-2031)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 China
9.1 China Biologic Therapeutic Drug Market Size (2020-2031)
9.2 China Biologic Therapeutic Drug Market Size by Type
9.2.1 China Biologic Therapeutic Drug Market Size by Type (2020-2025)
9.2.2 China Biologic Therapeutic Drug Market Size by Type (2026-2031)
9.2.3 China Biologic Therapeutic Drug Market Share by Type (2020-2031)
9.3 China Biologic Therapeutic Drug Market Size by Application
9.3.1 China Biologic Therapeutic Drug Market Size by Application (2020-2025)
9.3.2 China Biologic Therapeutic Drug Market Size by Application (2026-2031)
9.3.3 China Biologic Therapeutic Drug Market Share by Application (2020-2031)
10 Asia (Excluding China)
10.1 Asia Biologic Therapeutic Drug Market Size (2020-2031)
10.2 Asia Biologic Therapeutic Drug Market Size by Type
10.2.1 Asia Biologic Therapeutic Drug Market Size by Type (2020-2025)
10.2.2 Asia Biologic Therapeutic Drug Market Size by Type (2026-2031)
10.2.3 Asia Biologic Therapeutic Drug Market Share by Type (2020-2031)
10.3 Asia Biologic Therapeutic Drug Market Size by Application
10.3.1 Asia Biologic Therapeutic Drug Market Size by Application (2020-2025)
10.3.2 Asia Biologic Therapeutic Drug Market Size by Application (2026-2031)
10.3.3 Asia Biologic Therapeutic Drug Market Share by Application (2020-2031)
10.4 Asia Biologic Therapeutic Drug Market Size by Country
10.4.1 Asia Biologic Therapeutic Drug Market Size by Country (2020 VS 2024 VS 2031)
10.4.2 Asia Biologic Therapeutic Drug Market Size by Country (2020-2025)
10.4.3 Asia Biologic Therapeutic Drug Market Size by Country (2026-2031)
10.4.4 Asia Biologic Therapeutic Drug Market Share by Country (2020-2031)
10.4.5 Japan
10.4.6 South Korea
10.4.7 Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 South America, Middle East & Africa
11.1 South America, Middle East & Africa Biologic Therapeutic Drug Market Size (2020-2031)
11.2 South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Type
11.2.1 South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Type (2020-2025)
11.2.2 South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Type (2026-2031)
11.2.3 South America, Middle East & Africa Biologic Therapeutic Drug Market Share by Type (2020-2031)
11.3 South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Application
11.3.1 South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Application (2020-2025)
11.3.2 South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Application (2026-2031)
11.3.3 South America, Middle East & Africa Biologic Therapeutic Drug Market Share by Application (2020-2031)
11.4 South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Country
11.4.1 South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2020 VS 2024 VS 2031)
11.4.2 South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2020-2025)
11.4.3 South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2026-2031)
11.4.4 South America, Middle East & Africa Biologic Therapeutic Drug Market Share by Country (2020-2031)
11.4.5 Brazil
11.4.6 South Africa
11.4.7 Saudi Arabia
11.4.8 Turkey
11.4.9 Argentina
11.4.9 UAE
11.4.9 Egypt
11.4.9 Chile
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.